Andere Kunden interessierten sich auch für
![Insulin-like Growth Factors and Cancer]( "Insulin-like Growth Factors and Cancer")
Insulin-like Growth Factors and Cancer110,99 €![Nuclear Signaling Pathways and Targeting Transcription in Cancer]( "Nuclear Signaling Pathways and Targeting Transcription in Cancer")
Nuclear Signaling Pathways and Targeting Transcription in Cancer110,99 €![Tumor Models in Cancer Research]( "Tumor Models in Cancer Research")
Tumor Models in Cancer Research148,99 €![DNA Topoisomerases and Cancer]( "DNA Topoisomerases and Cancer")
DNA Topoisomerases and Cancer147,99 €![Bladder Tumors:]( "Bladder Tumors:")
Bladder Tumors:147,99 €![Vitamin D and Cancer]( "Vitamin D and Cancer")
Vitamin D and Cancer110,99 €![The Evolution of the Use of Mathematics in Cancer Research]( "The Evolution of the Use of Mathematics in Cancer Research")
The Evolution of the Use of Mathematics in Cancer Research110,99 €
The book will detail the history, successes, and failures of targeted therapies for cancer, with a particular focus on IGF systems and cancer.
The insulin-like growth factor system has been shown to play a critical role in cancer development and progression. Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics, specifically brings these aspects to the reader. The volume covers the epidemiological aspects of the relationships between circulating insulin and IGF-1 levels and the risk for cancer and cancer-related mortality and in particularly in disease states such as obesity and Type 2 diabetes. It then addresses the basic biology of the system and how the ligands, receptors and IGF-binding proteins affect cancer cell biology and cancer progression. Finally, it discusses the therapeutic potential of inhibiting the receptors using various newly discovered monoclonal antibodies and tyrosine kinase inhibitors that are in preclinical and clinical trials.
The insulin-like growth factor system has been shown to play a critical role in cancer development and progression. Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics, specifically brings these aspects to the reader. The volume covers the epidemiological aspects of the relationships between circulating insulin and IGF-1 levels and the risk for cancer and cancer-related mortality and in particularly in disease states such as obesity and Type 2 diabetes. It then addresses the basic biology of the system and how the ligands, receptors and IGF-binding proteins affect cancer cell biology and cancer progression. Finally, it discusses the therapeutic potential of inhibiting the receptors using various newly discovered monoclonal antibodies and tyrosine kinase inhibitors that are in preclinical and clinical trials.